New England Journal

Beyond's analysis on New England Journal

• 2026-07-09 — Betta's ensartinib shows promise as postoperative adjuvant therapy for ALK-positive NSCLC, potentially expanding its oncology portfolio after NEJM publication

Recent news mentioning New England Journal

• 2026-09-03 — Pulnovo Medical annonce les résultats de l'essai PADN-HF-PH lors du congrès de l'ESC 2026 ; ceux-ci sont publiés simultanément dans le New England Journal of Medicine (NEJM)
• 2026-09-03 — Pulnovo Medical gibt Ergebnisse der PADN-HF-PH-Studie auf dem ESC-Kongress 2026 bekannt; diese werden gleichzeitig im „New England Journal of Medicine" (NEJM) veröffentlicht
• 2026-09-03 — Pulnovo Medical Announces Results of the PADN-HF-PH Trial at ESC Congress 2026, Simultaneously Published in The New England Journal of Medicine (NEJM)
• 2026-09-03 — Pulnovo Medical Announces Results of the PADN-HF-PH Trial at ESC Congress 2026, Simultaneously Published in The New England Journal of Medicine (NEJM)

Appears alongside

• Pulnovo Medical
• Medicine NEJM
• PADN-HF-PH
• Ergebnisse
• PADN-HF-PH-Studie
• ESC-Kongress

Browse the full archive →